120
Participants
Start Date
January 11, 2019
Primary Completion Date
June 30, 2020
Study Completion Date
June 30, 2020
SPH3127 tablet Dose 1
Oral SPH3127 tablet, a kind of renion inhibitor, 50 mg, once daily for 8 weeks.
SPH3127 tablet Dose 2
Oral SPH3127 tablet, a kind of renion inhibitor, 100 mg, once daily for 8 weeks.
SPH3127 tablet Dose 3
Oral SPH3127 tablet, a kind of renion inhibitor, 200 mg, once daily for 8 weeks.
SPH3127 tablet Placebo
Oral SPH3127 tablet placebo, once daily for 8 weeks.
Beijing Anzhen Hospital, Capital Medical University, Beijing
Beijing Hospital, Beijing
The Second Xiangya Hospital of Central South University, Changsha
Xiangya Hospital Central South University, Changsha
West China Hospital of Sichuan University, Chengdu
Second People's Hospital of Guangdong Province, Guangdong
Inner Mongolia Medical University Affiliated Hospital, Hohhot
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Xuzhou Central Hospital, Xuzhou
R&G Pharma Studies Co.,Ltd.
INDUSTRY
Shanghai Pharmaceuticals Holding Co., Ltd
INDUSTRY